Announcements and latest updates

Mental Welfare Commission for Scotland - Authority to Discharge report

Webinar via Teams will be on 5 August, 2021 at 10am, until 11:15.

https://authoritytodischargereport.eventbrite.co.uk

Scottish National Psychiatry School

Friday 27 August 2021, 10am – 5pm (online platform TBC). To register your interest, contact Susan Richardson.

Home
Back
Medicines Companion
Medicines Guidance A-Z

Medicines Guidance A-Z

Alcohol withdrawal - in patient management protocol (MHS MRG 27)

Anaphylaxis - recognition and management (MHS 32)

Antidepressants - stopping & switching (MHS MRG 32)

Antipsychotics - combination and augmentation guidance (MHS MRG 16)

Antipsychotics - depot long-acting injection prescribing algorithm (MHS MRG 05)

Antipsychotics - effective use of first generation depot injections (MHS MRG 04)

Antipsychotics - high dose monitoring policy (MHS 34)

Antipsychotics - prescribing in dementia (MHS 31)

Antipsychotics - use of depot and long acting injections (MHS 30)

Benzatropine - protocol for unlicensed use (MHS MRG 18)

Clozapine - 15 day titration regime BLANK (MHS MRG 03.03.02)

Clozapine - 15 day titration regime STANDARD (MHS MRG 03.03.01)

Clozapine - developing a treatment plan for managing off licence use (MHS MRG 03.04)

Clozapine - options for initiation (MHS MRG 03.03)

Clozapine - out patient prescription form (MHS MRG 03.05)

Clozapine - patient holiday supplies (MHS MRG 03.10)

Clozapine - patient information standards (MHS MRG 03.09)

Clozapine - planned withdrawal

Clozapine - plasma monitoring guidance (MHS MRG 03 07)

Clozapine - protocol for rechallenge following a neutropenic episode (MHS MRG 03.11)

Clozapine - protocol for the use of Denzapine suspension (MHS MRG 03.06)

Clozapine - protocol for use of oro-dispersible tablets (MHS MRG 33)

Clozapine - re-titration following a treatment break (MHS MRG 3.14)

Clozapine - service standards (MHS MRG 03.01)

Clozapine - side effects monitoring care plan (MHS MRG 03.02)

Clozapine induced constipation - assessment and treatment (MHS MRG 03.08)

Controlled drugs - advice for checking stock (MHS MRG 10)

Covert medication and dysphagia - safe and cost effective administration (MHS MRG 02)

Covert medication policy (MHS 53)

Depression Treatment in Primary Care

Emergency cupboard list and procedure for out of hours access (MHS MRG 12)

Fluphenazine decanoate - protocol for unlicensed use (MHS MRG 35)

Haloperidol and QTc interval prolongation (MHS MRG 07)

Insomnia - management (MHS 35)

Insulin - safer use (MHS MRG 21)

Intramuscular medication for acutely disturbed behaviour (MHS 40)

Lithium - good practice standards (MHS MRG 26)

Lithium bundle (MHS MRG 24)

Lithium- patient information standards (MHS MRG 34)

Medication given out with prescribed times - administration and recording (MHS MRG 15)

Midazolam - intramuscular use for acutely disturbed behaviour (MHS MRG 06)

Neuroleptic malignant syndrome (MHS MRG 31)

Non-formulary and unlicensed medicines - advice on access (MHS MRG 08)

Non-formulary request form (MHS MRG 08.01)

Nurse dispensing outwith pharmacy hours (MHS MRG 14)

Off-label unlicensed prescribing guidance in MHS (MHS MRG 25)

Olanzapine - protocol for use of unlicensed injection (MHS MRG 23)

Opioids - safer use (MHS MRG 22)

Paracetamol overdose guidance (MHS MRG 17)

Pass medication - procedure for ordering (MHS 37)

Patients own drugs - procedure for use (MHS 38)

Physical healthcare policy (MHS 20)

Pirenzepine - protocol for unlicensed use (MHS MRG 19)

Prescribing as required psychotropic drugs (MHS MRG 28)

Prescription Sheet NHSGGC Mental Health - instructions for use (MHS MRG 09)

Problematic drug users - management of adults in NHSGGC acute hospitals (MHS MRG 11)

Psychotropic medication - reviewing care home residents

Response ward emergency tray locations (MHS MRG 13)

Safe secure handling of medicines in hospital wards (MHS MRG 01)

Serotonin syndrome (MHS MRG 30)

Symptomatic relief policy - adults and older adults (MHS 28)

Thioridazine - protocol for unlicensed use (MHS MRG 20)

Trazodone - appropriate formulation choice

Valproate pregnancy prevention programme

Zuclopenthixol Acetate (Clopixol Acuphase) (MHS 33)

Use of a second staff member 'runners' to deliver medication to the patient